Insider trading

Period: 120 months Stock: SDGR Plan: Scheduled (10b5-1) × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

33 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

33 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

33 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

33 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
33 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
33 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

33 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
17 Sep 2026
Akinsanya Karen See Remarks
Sold on a plan 2×
$927.97K 31,599 at 29.37
31.1%
Planned (10b5-1)
16 Jul 2026
Jain Rachit EVP & CFO
Sold on a plan
$13.65K 875 at 15.60
1.7%
Planned (10b5-1)
17 Apr 2026
Farid Ramy President & CEO
Sold on a plan
$524.94K 43,000 at 12.21
11.5%
Planned (10b5-1)
16 Apr 2026
Farid Ramy President & CEO
Sold on a plan
$530.23K 43,000 at 12.33
11.5%
Planned (10b5-1)
16 Apr 2026
Jain Rachit EVP & CFO
Sold on a plan
$10.76K 844 at 12.75
1.6%
Planned (10b5-1)
6 Mar 2026
Sold on a plan
$7.81K 608 at 12.84
1.7%
Planned (10b5-1)
5 Mar 2026
Farid Ramy President & CEO
Sold on a plan
$47.25K 3,661 at 12.91
1.1%
Planned (10b5-1)
5 Mar 2026
Jain Rachit EVP & CFO
Sold on a plan
$21.03K 1,631 at 12.90
3.0%
Planned (10b5-1)
5 Mar 2026
Akinsanya Karen See Remarks
Sold on a plan
$17.63K 1,366 at 12.90
1.9%
Planned (10b5-1)
5 Mar 2026
Lorton Kenneth Patrick EVP, CTO & COO, Software
Sold on a plan
$15.76K 1,222 at 12.90
1.4%
Planned (10b5-1)
5 Mar 2026
Tran Yvonne EVP, CLO & CPO
Sold on a plan
$14.11K 1,094 at 12.90
2.0%
Planned (10b5-1)
5 Mar 2026
Sold on a plan
$9.96K 775 at 12.85
2.1%
Planned (10b5-1)
4 Mar 2026
Abel Robert Lorne See Remarks
Sold on a plan
$16.65K 1,300 at 12.81
2.3%
Planned (10b5-1)
2 Mar 2026
Farid Ramy President & CEO
Sold on a plan
$66.15K 5,560 at 11.90
1.6%
Planned (10b5-1)
2 Mar 2026
Akinsanya Karen See Remarks
Sold on a plan
$26.45K 2,206 at 11.99
3.0%
Planned (10b5-1)
10 Feb 2026
Lorton Kenneth Patrick EVP, CTO & COO, Software
Sold on a plan
$12.70K 925 at 13.73
1.7%
Planned (10b5-1)
10 Feb 2026
Tran Yvonne EVP, CLO & CPO
Sold on a plan
$10.71K 776 at 13.80
3.3%
Planned (10b5-1)
10 Feb 2026
Sold on a plan
$10.37K 752 at 13.79
2.7%
Planned (10b5-1)
9 Feb 2026
Abel Robert Lorne See Remarks
Sold on a plan
$16.62K 1,230 at 13.51
6.0%
Planned (10b5-1)
16 Oct 2025
Dugan Margaret Chief Medical Officer
Sold on a plan
$29.39K 1,395 at 21.07
5.4%
Planned (10b5-1)
14 Apr 2025
Akinsanya Karen President of R&D, Therapeutics
Sold on a plan 3×
$419.57K 16,723 at 25.09
51.7%
Sold half or more
6 Mar 2025
Herman Jenny SVP & Controller
Sold on a plan
$14.06K 666 at 21.11
2.4%
Planned (10b5-1)
18 Feb 2025
Tran Yvonne EVP, CLO & CPO
Sold on a plan
$109.26K 3,902 at 28.00
25.9%
Planned (10b5-1)
11 Feb 2025
Lorton Kenneth Patrick EVP, CTO & COO, Software
Sold on a plan
$24.06K 985 at 24.43
2.3%
Planned (10b5-1)
11 Feb 2025
Herman Jenny SVP & Controller
Sold on a plan
$20.99K 859 at 24.43
4.5%
Planned (10b5-1)
11 Feb 2025
Tran Yvonne EVP, CLO & CPO
Sold on a plan
$20.23K 828 at 24.43
6.9%
Planned (10b5-1)
10 Feb 2025
Abel Robert Lorne See Remarks
Sold on a plan
$31.84K 1,225 at 25.99
13.1%
Planned (10b5-1)
15 Oct 2024
Dugan Margaret Chief Medical Officer
Sold on a plan
$27.23K 1,531 at 17.78
10.2%
Planned (10b5-1)
12 Feb 2024
Abel Robert Lorne See Remarks
Sold on a plan
$33.20K 1,205 at 27.55
11.4%
Planned (10b5-1)
12 Feb 2024
Lorton Kenneth Patrick EVP, CTO & COO, Software
Sold on a plan
$25.49K 901 at 28.29
2.4%
Planned (10b5-1)
12 Feb 2024
Herman Jenny SVP & Controller
Sold on a plan
$22.26K 787 at 28.29
6.3%
Planned (10b5-1)
12 Feb 2024
Tran Yvonne EVP, CLO & CPO
Sold on a plan
$21.44K 758 at 28.29
6.0%
Planned (10b5-1)
9 Aug 2023
Lorton Kenneth Patrick EVP & Chief Technology Officer
Sold on a plan
$400.64K 10,000 at 40.06
21.1%
Planned (10b5-1)
Showing 1–33 of 33.